Patent · US Active

Method for determining oversensing in an implantable device

US7831304B2 · kind B2 · utility

33Cited by
12References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 29, 2006
Grant dateNov 9, 2010
Priority date
Expiry dateSep 9, 2029

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16H50/20
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

An implantable medical device system and method detect oversensing of cardiac signals. A cardiac signal including first events and second events is acquired. Cardiac events are sensed in response to the cardiac signal crossing a first threshold. A filtered cardiac signal is determined from the sensed cardiac signal, and a second threshold is determined from the filtered cardiac signal. A sensed cardiac event is classified either as a first event when the sensed cardiac event corresponds to a filtered cardiac signal peak crossing the second threshold or a second event when the sensed cardiac event corresponds to a filtered cardiac signal peak being less than the second threshold. Classification of sensed cardiac events as second events is used in determining oversensing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.